A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System

NCT01184456 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

HIV Infection
Gastrointestinal Symptoms

Interventions

DIETARY_SUPPLEMENT: GanedenBC30, GBI-30, PTA-6086
DRUG: Placebo

Sponsor

AIDS Healthcare Foundation

Collaborators

[object Object]